Canagliflozin in Patients With Acute Decompensated Heart Failure
Status:
Not yet recruiting
Trial end date:
2023-11-09
Target enrollment:
Participant gender:
Summary
The study aims to investigate the efficacy and safety of the early initiation of
canagliflozin treatment in hospitalized heart failure patients with volume overload
(warm-wet) who require the use of I.V loop diuretic during the hospitalization period.